CHAMPIONS ONCOLOGY, INC. Finance Lease, Right-of-Use Asset, Amortization
CHAMPIONS ONCOLOGY, INC. (CSBR) reported Finance Lease, Right-of-Use Asset, Amortization of $19.00 thousand for the 3-month period ending 2026-07-31, per its 10-Q filed 2026-09-11.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:FinanceLeaseRightOfUseAssetAmortization · last filed 2026-09-11
- CHAMPIONS ONCOLOGY, INC. finance lease, right-of-use asset, amortization for the quarter ending 2026-07-31 was $19.00K, a 50.00% decline year-over-year.
- CHAMPIONS ONCOLOGY, INC. finance lease, right-of-use asset, amortization for the quarter ending 2026-04-30 was $19.00K, a 50.00% decline year-over-year.
- CHAMPIONS ONCOLOGY, INC. finance lease, right-of-use asset, amortization for the quarter ending 2026-01-31 was $39.00K, a 2.63% increase year-over-year.
- CHAMPIONS ONCOLOGY, INC. finance lease, right-of-use asset, amortization for the quarter ending 2025-10-31 was $39.00K, a 5.41% increase year-over-year.
- CHAMPIONS ONCOLOGY, INC. finance lease, right-of-use asset, amortization for fiscal 2026 was $135.00K, a 10.00% decline from fiscal 2025.
- CHAMPIONS ONCOLOGY, INC. finance lease, right-of-use asset, amortization for fiscal 2025 was $150.00K, a 2.74% increase from fiscal 2024.
- CHAMPIONS ONCOLOGY, INC. finance lease, right-of-use asset, amortization for fiscal 2024 was $146.00K, a 8.15% increase from fiscal 2023.
- CHAMPIONS ONCOLOGY, INC. finance lease, right-of-use asset, amortization for fiscal 2023 was $135.00K.
| Period end | Finance Lease, Right-of-Use Asset, Amortization 3 month | Finance Lease, Right-of-Use Asset, Amortization 3 month as first filed | Finance Lease, Right-of-Use Asset, Amortization 6 month | Finance Lease, Right-of-Use Asset, Amortization 9 month | Finance Lease, Right-of-Use Asset, Amortization 9 month as first filed | Finance Lease, Right-of-Use Asset, Amortization 12 month |
|---|---|---|---|---|---|---|
| 2026-07-31 | $19.00K 10-Q · filed 2026-09-11 | $38.00K derived: sum of 2 quarters · filed 2026-09-11 | $77.00K derived: sum of 3 quarters · filed 2026-09-11 | $116.00K derived: sum of 4 quarters · filed 2026-09-11 | ||
| 2026-04-30 | $19.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-27 | $58.00K derived: sum of 2 quarters · filed 2026-07-27 | $97.00K derived: sum of 3 quarters · filed 2026-07-27 | $135.00K 10-K · filed 2026-07-27 | ||
| 2026-01-31 | $39.00K 10-Q · filed 2026-03-12 | $78.00K derived: sum of 2 quarters · filed 2026-03-12 | $116.00K 10-Q · filed 2026-03-12 | $154.00K derived: sum of 4 quarters · filed 2026-09-11 | ||
| 2025-10-31 | $39.00K 10-Q · filed 2025-12-15 | $77.00K 10-Q · filed 2025-12-15 | $115.00K derived: sum of 3 quarters · filed 2026-09-11 | $153.00K derived: sum of 4 quarters · filed 2026-09-11 | ||
| 2025-07-31 | $38.00K 10-Q · filed 2026-09-11 | $76.00K derived: sum of 2 quarters · filed 2026-09-11 | $114.00K derived: sum of 3 quarters · filed 2026-09-11 | $151.00K derived: sum of 4 quarters · filed 2026-09-11 | ||
| 2025-04-30 | $38.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-27 | $76.00K derived: sum of 2 quarters · filed 2026-07-27 | $113.00K derived: sum of 3 quarters · filed 2026-07-27 | $150.00K 10-K · filed 2026-07-27 | ||
| 2025-01-31 | $38.00K 10-Q · filed 2026-03-12 | $75.00K derived: sum of 2 quarters · filed 2026-03-12 | $112.00K 10-Q · filed 2026-03-12 | $150.00K derived: sum of 4 quarters · filed 2026-03-12 | ||
| 2024-10-31 | $37.00K 10-Q · filed 2025-12-15 | $74.00K 10-Q · filed 2025-12-15 | $112.00K derived: sum of 3 quarters · filed 2025-12-15 | $148.00K derived: sum of 4 quarters · filed 2025-12-15 | ||
| 2024-07-31 | $37.00K 10-Q · filed 2025-09-15 | $75.00K derived: sum of 2 quarters · filed 2025-09-15 | $111.00K derived: sum of 3 quarters · filed 2025-09-15 | $147.00K derived: sum of 4 quarters · filed 2025-09-15 | ||
| 2024-04-30 | $38.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-07-23 | $74.00K derived: sum of 2 quarters · filed 2025-07-23 | $110.00K derived: sum of 3 quarters · filed 2025-07-23 | $146.00K 10-K · filed 2025-07-23 | ||
| 2024-01-31 | $36.00K 10-Q · filed 2025-03-17 | $72.00K derived: sum of 2 quarters · filed 2025-03-17 | $108.00K 10-Q · filed 2025-03-17 | |||
| 2023-10-31 | $36.00K 10-Q · filed 2024-12-16 | $72.00K 10-Q · filed 2024-12-16 | ||||
| 2023-07-31 | $36.00K 10-Q · filed 2024-09-13 | |||||
| 2023-04-30 | $135.00K 10-K · filed 2024-07-19 | |||||
| 2022-01-31 | $0.00 10-Q · filed 2022-03-15 | $0.00 derived: sum of 2 quarters · filed 2022-03-15 | $0.00 10-Q · filed 2022-03-15 | $71.00K derived: sum of 4 quarters · filed 2022-03-15 | ||
| 2021-10-31 | $0.00 10-Q · filed 2021-12-13 | $0.00 10-Q · filed 2021-12-13 | $71.00K derived: sum of 3 quarters · filed 2021-12-13 | $124.00K derived: sum of 4 quarters · filed 2022-03-15 | ||
| 2021-07-31 | $53.00K 10-Q · filed 2021-09-13 | $71.00K derived: sum of 2 quarters · filed 2021-09-13 | $124.00K derived: sum of 3 quarters · filed 2022-03-15 | $177.00K derived: sum of 4 quarters · filed 2022-03-15 | ||
| 2021-04-30 | $18.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-07-26 | $71.00K derived: sum of 2 quarters · filed 2022-03-15 | $124.00K derived: sum of 3 quarters · filed 2022-03-15 | $124.00K 10-K · filed 2021-07-26 | ||
| 2021-01-31 | $53.00K 10-Q · filed 2022-03-15 | $18.00K 10-Q · filed 2021-03-15 | $106.00K derived: sum of 2 quarters · filed 2022-03-15 | $106.00K 10-Q · filed 2022-03-15 | $124.00K 10-Q · filed 2021-03-15 | $106.50K derived: sum of 4 quarters · filed 2022-03-15 |
| 2020-10-31 | $53.00K 10-Q · filed 2021-12-13 | $53.10K 10-Q · filed 2020-12-14 | $106.00K 10-Q · filed 2021-12-13 | $53.50K derived: sum of 3 quarters · filed 2021-12-13 | $88.50K derived: sum of 4 quarters · filed 2021-12-13 | |
| 2020-07-31 | $0.00 10-Q · filed 2021-09-13 | $53.10K 10-Q · filed 2020-09-14 | $500.00 derived: sum of 2 quarters · filed 2021-09-13 | $35.50K derived: sum of 3 quarters · filed 2021-09-13 | $35.50K derived: sum of 4 quarters · filed 2021-09-13 | |
| 2020-04-30 | $500.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-07-26 | $35.50K derived: sum of 2 quarters · filed 2021-07-26 | $35.50K derived: sum of 3 quarters · filed 2021-07-26 | $88.50K 10-K · filed 2021-07-26 | ||
| 2020-01-31 | $35.00K 10-Q · filed 2021-03-15 | $35.40K 10-Q · filed 2020-03-16 | $35.00K derived: sum of 2 quarters · filed 2021-03-15 | $88.00K 10-Q · filed 2021-03-15 | $35.40K 10-Q · filed 2020-03-16 | |
| 2019-10-31 | $0.00 10-Q · filed 2020-12-14 | $0.00 10-Q · filed 2020-12-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |